Aus HL7 Austria MediaWiki
Hauptseite > 1.2.40.0.34.10.44/static-2013-09-12T000000
Version vom 18. Oktober 2017, 04:22 Uhr
Id | 1.2.40.0.34.10.44 | Gültigkeit | gültig ab 2013‑09‑12 |
---|
Status | Veraltet | Versions-Label | |
---|
Name | ELGA_Laborparameter | Anzeigename | ELGA_Laborparameter |
---|
2 Quell-Codesysteme | 1.2.40.0.34.5.11 2.16.840.1.113883.6.1 |
---|
Level/ Typ | Code | Anzeigename | Codesystem |
---|
0‑S | 100 | Blutgruppenserologie/Immungenetik | 1.2.40.0.34.5.11 | 1‑L | 101 | Blutgruppenserologie | 1.2.40.0.34.5.11 | 1‑L | 102 | HLA-Diagnostik | 1.2.40.0.34.5.11 | 1‑L | 103 | HPA-Diagnostik | 1.2.40.0.34.5.11 | 0‑S | 200 | Blutgasanalyse | 1.2.40.0.34.5.11 | 1‑S | 201 | Blutgasanalyse Arteriell | 1.2.40.0.34.5.11 | 2‑L | 2744-1 | pH arteriell | 2.16.840.1.113883.6.1 | 2‑L | 2019-8 | pCO2 arteriell | 2.16.840.1.113883.6.1 | 2‑L | 2703-7 | pO2 arteriell | 2.16.840.1.113883.6.1 | 2‑L | 1925-7 | Base excess art. | 2.16.840.1.113883.6.1 | 2‑L | 2714-4 | FO2-Hb arteriell | 2.16.840.1.113883.6.1 | 2‑L | 1960-4 | Bikarbonat arteriell | 2.16.840.1.113883.6.1 | 2‑L | 2708-6 | O2-Sättigung art. | 2.16.840.1.113883.6.1 | 1‑S | 202 | Blutgasanalyse Venös | 1.2.40.0.34.5.11 | 2‑L | 2746-6 | pH venös | 2.16.840.1.113883.6.1 | 2‑L | 2021-4 | pCO2 venös | 2.16.840.1.113883.6.1 | 2‑L | 2705-2 | pO2 venös | 2.16.840.1.113883.6.1 | 2‑L | 1927-3 | Base excess venös | 2.16.840.1.113883.6.1 | 2‑L | 2716-9 | FO2-Hb venös | 2.16.840.1.113883.6.1 | 2‑L | 14627-4 | Bikarbonat venös | 2.16.840.1.113883.6.1 | 2‑L | 2711-0 | O2-Sättigung venös | 2.16.840.1.113883.6.1 | 1‑L | 203 | Blutgasanalyse Nabelschnurblut | 1.2.40.0.34.5.11 | 2‑L | 2745-8 | pH /KB | 2.16.840.1.113883.6.1 | 2‑L | 2020-6 | pCO2 /KB | 2.16.840.1.113883.6.1 | 2‑L | 2704-5 | PO2 /KB | 2.16.840.1.113883.6.1 | 2‑L | 1926-5 | Base excess /KB | 2.16.840.1.113883.6.1 | 2‑L | 1961-2 | Bikarbonat /KB | 2.16.840.1.113883.6.1 | 2‑L | 2709-4 | O2-Sättigung /KB | 2.16.840.1.113883.6.1 | 0‑S | 300 | Hämatologie | 1.2.40.0.34.5.11 | 1‑S | 301 | Blutbild | 1.2.40.0.34.5.11 | 2‑L | 26464-8 | Leukozyten | 2.16.840.1.113883.6.1 | 2‑L | 26515-7 | Thrombozyten | 2.16.840.1.113883.6.1 | 2‑L | 778-1 | Thrombozyten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 26453-1 | Erythrozyten | 2.16.840.1.113883.6.1 | 2‑L | 718-7 | Hämoglobin | 2.16.840.1.113883.6.1 | 2‑L | 20570-8 | Hämatokrit | 2.16.840.1.113883.6.1 | 2‑L | 28539-5 | MCH | 2.16.840.1.113883.6.1 | 2‑L | 30428-7 | MCV | 2.16.840.1.113883.6.1 | 2‑L | 28540-3 | MCHC | 2.16.840.1.113883.6.1 | 2‑L | 26499-4 | Neutroph. Gran. abs. | 2.16.840.1.113883.6.1 | 2‑L | 26474-7 | Lymphozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 26484-6 | Monozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 26449-9 | Eosinophile Gr. abs. | 2.16.840.1.113883.6.1 | 2‑L | 26444-0 | Basophile Gr.abs. | 2.16.840.1.113883.6.1 | 2‑L | 51584-1 | Gran., unreife abs. | 2.16.840.1.113883.6.1 | 2‑L | 26511-6 | Neutroph. Gran. rel. | 2.16.840.1.113883.6.1 | 2‑L | 26478-8 | Lymphozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 26485-3 | Monozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 26450-7 | Eosinophile Gr. rel. | 2.16.840.1.113883.6.1 | 2‑L | 30180-4 | Basophile Gr.rel. | 2.16.840.1.113883.6.1 | 2‑L | 38518-7 | Gran., unreife rel. | 2.16.840.1.113883.6.1 | 2‑L | 51588-2 | Ganulozyten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 763-3 | Stabkernige abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 768-2 | Segmentkern. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 739-3 | Metamyeloz. abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 748-4 | Myelozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 781-5 | Promyelozyt. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 708-8 | Blasten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 732-8 | Lymphozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | AKLAM | Akt.Lymphoz.abs.mi. | 1.2.40.0.34.5.11 | 2‑L | 734-4 | Atyp.Lymphoz.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 35082-7 | LGL abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 24103-4 | Plasmazellen abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 33834-3 | Plasm.Lymphoz.ab.mi. | 2.16.840.1.113883.6.1 | 2‑L | 6863-5 | Prolymphozyt.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 24107-5 | Haarzellen abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 743-5 | Monozyten abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 712-0 | Eosinoph.Gr.abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 705-4 | Basophile Gr.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 33856-6 | Sezary-Zel. abs. mi. | 2.16.840.1.113883.6.1 | 2‑L | 51585-8 | Sonstige Zel.abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 764-1 | Stabkernige rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 769-0 | Segmentkern. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 28541-1 | Metamyeloz. rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 749-2 | Myelozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 783-1 | Promyelozyt. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 709-6 | Blasten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 737-7 | Lymphozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | AKLRM | Akt.Lymphoz.rel.mi. | 1.2.40.0.34.5.11 | 2‑L | 735-1 | Atyp.Lymphoz.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 733-6 | Atyp.Lymphoz.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 11275-5 | LGL rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 13047-6 | Plasmazellen rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 40743-7 | Plasmazellen ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 33835-0 | Plasm.Lymphoz.rl.mi. | 2.16.840.1.113883.6.1 | 2‑L | 6746-2 | Prolymphozyt.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 24106-7 | Haarzellen rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 33857-4 | Sezary-Zel. rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 744-3 | Monozyten rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 714-6 | Eosinoph.Gr.rel. mi. | 2.16.840.1.113883.6.1 | 2‑L | 707-0 | Basophile Gr.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51586-6 | Sonstige Zel.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51644-3 | Megakar.kerne ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 738-5 | Makrozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 51645-0 | Mikromegakary.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 34992-8 | Kernschatten rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7798-2 | Kernschatten ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 765-8 | Hypersegment. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 803-7 | Toxische Gran.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 34993-6 | Kernschatten abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 10378-8 | Polychromasie ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 779-9 | Poikilozytose ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 741-9 | Mikrozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10376-2 | Megalozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 802-9 | Kugelzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 728-6 | Hypochomasie ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 7793-3 | Howell-Jolly. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51630-2 | Fragmentozyt.rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 800-3 | Fragmentozyt. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51638-5 | Ery.aggregate ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 11274-8 | Elliptozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 7790-9 | Echinozyten ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51589-0 | Dyserythrop. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 10377-0 | Bleistiftzel. ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 703-9 | Basoph.Tüpfelung mi. | 2.16.840.1.113883.6.1 | 2‑L | 51583-3 | Anulozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 702-1 | Anisozytose ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 51582-5 | Anisochromas.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51639-3 | Akanthozyten rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 7789-1 | Akanthozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 7791-7 | Tränenzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10381-2 | Target-Zellen mi. | 2.16.840.1.113883.6.1 | 2‑L | 7797-4 | Geldrollenb. ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 10380-4 | Stomatozyten ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 801-1 | Sichelzellen ql. mi. | 2.16.840.1.113883.6.1 | 2‑L | 5909-7 | Blutausstr. Interpr. | 2.16.840.1.113883.6.1 | 2‑L | 50794-7 | Osm.E.R.Hämol.beginn | 2.16.840.1.113883.6.1 | 2‑L | 50795-4 | Osm.E.R.Totalhämol. | 2.16.840.1.113883.6.1 | 2‑L | 34964-7 | Osmot.E.R. Interpr. | 2.16.840.1.113883.6.1 | 2‑L | 4679-7 | Retikulozyten rel. | 2.16.840.1.113883.6.1 | 2‑L | 31112-6 | Retikulozyt. rel.mi. | 2.16.840.1.113883.6.1 | 2‑L | 14196-0 | Retikulozyten abs. | 2.16.840.1.113883.6.1 | 2‑L | 40665-2 | Retikulozyt. abs.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51636-9 | IRF(Ret.,unreif)abs. | 2.16.840.1.113883.6.1 | 2‑L | 33516-6 | IRF(Ret.,unreif)rel. | 2.16.840.1.113883.6.1 | 2‑L | 51634-4 | Reti,mittelreif abs. | 2.16.840.1.113883.6.1 | 2‑L | 34420-0 | Reti,mittelreif rel. | 2.16.840.1.113883.6.1 | 2‑L | 51635-1 | Reti., reif abs. | 2.16.840.1.113883.6.1 | 2‑L | 34419-2 | Reti., reife rel. | 2.16.840.1.113883.6.1 | 2‑L | 51643-5 | HLSc-Reti. abs. | 2.16.840.1.113883.6.1 | 2‑L | 51642-7 | HLSc-Reti. rel. | 2.16.840.1.113883.6.1 | 2‑L | 42810-2 | Retikulozyten Hb | 2.16.840.1.113883.6.1 | 2‑L | 30392-5 | Normoblast.(NRBC)ab. | 2.16.840.1.113883.6.1 | 2‑L | 19048-8 | Normoblast.(NRBC)Rt. | 2.16.840.1.113883.6.1 | 2‑L | 18309-5 | Normobl.(NRBC)Rt.mi. | 2.16.840.1.113883.6.1 | 2‑L | 772-4 | Normobl.(NRBC)ab.mi. | 2.16.840.1.113883.6.1 | 2‑L | 30385-9 | RDW-CV | 2.16.840.1.113883.6.1 | 2‑L | 30384-2 | RDW-SD | 2.16.840.1.113883.6.1 | 2‑L | 28542-9 | MPV | 2.16.840.1.113883.6.1 | 2‑L | 32207-3 | PDW-SD | 2.16.840.1.113883.6.1 | 2‑L | 51631-0 | PDW-CV | 2.16.840.1.113883.6.1 | 2‑L | 51632-8 | Retik.Thromboz.abs. | 2.16.840.1.113883.6.1 | 2‑L | 51633-6 | Retik.Thromboz.rel. | 2.16.840.1.113883.6.1 | 2‑L | 7796-6 | Thromboz.aggr.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 51640-1 | Thro.anisozyt.ql.mi. | 2.16.840.1.113883.6.1 | 2‑L | 5908-9 | Riesenthromb. ql.mi. | 2.16.840.1.113883.6.1 | 1‑S | 302 | Knochenmark Morphologie | 1.2.40.0.34.5.11 | 2‑L | 11128-6 | Segm.Gran. rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11103-9 | Stabk.Gran. rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11111-2 | Metamyeloz.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11114-6 | Myelozyten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11120-3 | Promyeloz. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11113-8 | Myeloblasten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11108-8 | Lymphozyten rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11118-7 | Plasmaz. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11112-0 | Monozyten rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11106-2 | Eos.Gran.rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11105-4 | Basoph.Gran.rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11150-0 | Blasten rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 51579-1 | Normoblast. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 51629-4 | Makroblast. rel. /KM | 2.16.840.1.113883.6.1 | 2‑L | 11124-5 | Proerythrobl.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 11110-4 | Megakaryozy.rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 51580-9 | Makrophagen rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 51581-7 | Sonst.Zellen rel./KM | 2.16.840.1.113883.6.1 | 2‑L | 13513-7 | Eisenfärbung /KM | 2.16.840.1.113883.6.1 | 2‑L | 11016-3 | Esterase-Fbg (unsp.) | 2.16.840.1.113883.6.1 | 2‑L | 9786-5 | PAS-Färbung | 2.16.840.1.113883.6.1 | 2‑L | 11018-9 | POX(Peroxidase)-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 11020-5 | Saure-Phosphat.-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 11019-7 | Sudan-Schwarz-Fbg | 2.16.840.1.113883.6.1 | 2‑L | 51628-6 | KM-Befundinterpr. | 2.16.840.1.113883.6.1 | 1‑S | 303 | Immunphänotypisierung | 1.2.40.0.34.5.11 | 2‑L | FZA10AK | FZA10AK | 1.2.40.0.34.5.11 | 2‑L | FZA4R | FZA4R | 1.2.40.0.34.5.11 | 2‑L | FZA510AK | FZA510AK | 1.2.40.0.34.5.11 | 2‑L | FZA5AK | FZA5AK | 1.2.40.0.34.5.11 | 2‑L | FZAKLEU | FZAKLEU | 1.2.40.0.34.5.11 | 2‑L | FZALZP | FZALZP | 1.2.40.0.34.5.11 | 2‑L | FZBAL | FZBAL | 1.2.40.0.34.5.11 | 2‑L | FZDNA | FZDNA | 1.2.40.0.34.5.11 | 2‑L | FZIMSTA | FZIMSTA | 1.2.40.0.34.5.11 | 2‑L | FZLK | FZLK | 1.2.40.0.34.5.11 | 2‑L | FZLYPA | FZLYPA | 1.2.40.0.34.5.11 | 2‑L | FZMYVD | FZMYVD | 1.2.40.0.34.5.11 | 2‑L | FZMYVL | FZMYVL | 1.2.40.0.34.5.11 | 2‑L | FZZAP70 | FZZAP70 | 1.2.40.0.34.5.11 | 1‑S | 304 | Molekulare Diagnostik | 1.2.40.0.34.5.11 | 0‑S | 400 | Hämostaseologie | 1.2.40.0.34.5.11 | 1‑S | 401 | Hämostaseologie Globaltests | 1.2.40.0.34.5.11 | 2‑L | 11067-6 | Blutungszeit n. Duke | 2.16.840.1.113883.6.1 | 2‑L | CFTIN | Clot Form.Time INTEM | 1.2.40.0.34.5.11 | 2‑L | CFTEX | Clot Form.Time EXTEM | 1.2.40.0.34.5.11 | 2‑L | CFTNA | Clot Form.Time NATEM | 1.2.40.0.34.5.11 | 2‑L | CTAPT | Clotting Time APTEM | 1.2.40.0.34.5.11 | 2‑L | CTEXT | Clotting Time EXTEM | 1.2.40.0.34.5.11 | 2‑L | CTHEP | Clotting Time HEPTEM | 1.2.40.0.34.5.11 | 2‑L | CTINT | Clotting Time INTEM | 1.2.40.0.34.5.11 | 2‑L | CTNAT | Clotting Time NATEM | 1.2.40.0.34.5.11 | 2‑L | MCFEX | Max.Clot Firmn.EXTEM | 1.2.40.0.34.5.11 | 2‑L | MCFFI | Max.Clot Firmn.FIBT. | 1.2.40.0.34.5.11 | 2‑L | MCFIN | Max.Clot Firmn.INTEM | 1.2.40.0.34.5.11 | 2‑L | MCFNA | Max.Clot Firmn.NATEM | 1.2.40.0.34.5.11 | 2‑L | MLEXT | Maximal Lyse EXTEM | 1.2.40.0.34.5.11 | 2‑L | MLINT | Maximal Lyse INTEM | 1.2.40.0.34.5.11 | 2‑L | MLNAT | Maximal Lyse NATEM | 1.2.40.0.34.5.11 | 2‑L | 3183-1 | Ger.zeit Lee/White | 2.16.840.1.113883.6.1 | 2‑L | NRMTC | Normotest /KB | 1.2.40.0.34.5.11 | 2‑L | 46418-0 | INR /KB | 2.16.840.1.113883.6.1 | 2‑L | THRTC | Thrombotest /KB | 1.2.40.0.34.5.11 | 2‑L | 5894-1 | PTZ (Prothrombinz.) | 2.16.840.1.113883.6.1 | 2‑L | NORMT | Normotest | 1.2.40.0.34.5.11 | 2‑L | 6301-6 | INR | 2.16.840.1.113883.6.1 | 2‑L | THROT | Thrombotest | 1.2.40.0.34.5.11 | 2‑L | INRTT | INRTT | 1.2.40.0.34.5.11 | 2‑L | INRST | INRST | 1.2.40.0.34.5.11 | 2‑L | 14979-9 | aPTT | 2.16.840.1.113883.6.1 | 2‑L | APTTF | aPTT Fakt.-sens. | 1.2.40.0.34.5.11 | 2‑L | 3243-3 | Thrombinzeit | 2.16.840.1.113883.6.1 | 2‑L | 6683-7 | Reptilasezeit | 2.16.840.1.113883.6.1 | 2‑L | 3255-7 | Fibrinogen | 2.16.840.1.113883.6.1 | 2‑L | 3256-5 | Fibrinogen Antigen | 2.16.840.1.113883.6.1 | 2‑L | 27811-9 | AT III Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 30240-6 | D-Dimer | 2.16.840.1.113883.6.1 | 2‑L | 3264-9 | Fibrinopept. A (FPA) | 2.16.840.1.113883.6.1 | 2‑L | 25742-8 | Prothrombinfrg. F1+2 | 2.16.840.1.113883.6.1 | 2‑L | 3274-8 | UF-Heparin(a-FXa Ak) | 2.16.840.1.113883.6.1 | 2‑L | 3271-4 | LMW-Hep.(a-FXa Akt.) | 2.16.840.1.113883.6.1 | 2‑L | 28652-6 | Danaparoid(a-FXa Ak) | 2.16.840.1.113883.6.1 | 2‑L | 24472-3 | PFA 100 / ADP | 2.16.840.1.113883.6.1 | 2‑L | 24471-5 | PFA 100 / Epinephrin | 2.16.840.1.113883.6.1 | 2‑L | PFAINT | PFAINT | 1.2.40.0.34.5.11 | 2‑L | 34701-3 | Heparin-PF4-ind.AK | 2.16.840.1.113883.6.1 | 1‑S | 402 | Einzelfaktoranalysen | 1.2.40.0.34.5.11 | 2‑L | 27813-5 | Faktor II Antigen | 2.16.840.1.113883.6.1 | 2‑L | 3193-0 | Faktor V Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3191-4 | Faktor V Inhibitor | 2.16.840.1.113883.6.1 | 2‑L | 3198-9 | Faktor VII Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3218-5 | Faktor X Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3209-4 | Faktor VIII Akt. | 2.16.840.1.113883.6.1 | 2‑L | 3204-5 | Faktor VIII Inhib. | 2.16.840.1.113883.6.1 | 2‑L | 3187-2 | Faktor IX Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3185-6 | Faktor IX Inhibitor | 2.16.840.1.113883.6.1 | 2‑L | 3226-8 | Faktor XI Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 3232-6 | Faktor XII Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 27815-0 | Faktor XIII Akt. | 2.16.840.1.113883.6.1 | 2‑L | HMWKA | HMWK Aktivität | 1.2.40.0.34.5.11 | 2‑L | 28659-1 | Präkallikrein | 2.16.840.1.113883.6.1 | 2‑L | PKA | Präkallikrein Akt. | 1.2.40.0.34.5.11 | 2‑L | V00006 | FXIII Akt.Clot-Lysis | 1.2.40.0.34.5.11 | 2‑L | VWGPI | vWF Aktiv. (GPIb-R) | 1.2.40.0.34.5.11 | 2‑L | 27816-8 | vWillebrand Fakt.AG | 2.16.840.1.113883.6.1 | 2‑L | 6013-7 | vWF-Multimere | 2.16.840.1.113883.6.1 | 2‑L | 6014-5 | vWF-Ristoc.Kof.Akt. | 2.16.840.1.113883.6.1 | 2‑L | ADAA | ADAMTS 13 Aktivität | 1.2.40.0.34.5.11 | 2‑L | 40824-5 | ADAMTS 13 Inhibitor | 2.16.840.1.113883.6.1 | 2‑L | 27810-1 | Antiplasmin Akt. | 2.16.840.1.113883.6.1 | 2‑L | 28660-9 | Plasminogen Akt. | 2.16.840.1.113883.6.1 | 2‑L | 5974-1 | Plasmin.Akt.Inhib-1 | 2.16.840.1.113883.6.1 | 1‑S | 403 | Thrombophilie Tests | 1.2.40.0.34.5.11 | 2‑L | 34571-0 | aPTT Lupus-sensitiv | 2.16.840.1.113883.6.1 | 2‑L | 34573-6 | aPTT Lupus-s. 1+1 NP | 2.16.840.1.113883.6.1 | 2‑L | PTTL2 | aPTT Lupus-s. 1+2 NP | 1.2.40.0.34.5.11 | 2‑L | LABPQ | LA-Bestät. aPTT ql. | 1.2.40.0.34.5.11 | 2‑L | 6303-2 | dRVVT | 2.16.840.1.113883.6.1 | 2‑L | 34569-4 | dRVVT 1+1 NP | 2.16.840.1.113883.6.1 | 2‑L | dRVV2 | dRVVT 1+2 NP | 1.2.40.0.34.5.11 | 2‑L | LBDR1 | LA Bst.dRVVT-R.1+1NP | 1.2.40.0.34.5.11 | 2‑L | LBDR2 | LA Bst.dRVVT-R.1+2NP | 1.2.40.0.34.5.11 | 2‑L | 34570-2 | LA Best.dRVVT 1+1 NP | 2.16.840.1.113883.6.1 | 2‑L | LABD2 | LA Best.dRVVT 1+2 NP | 1.2.40.0.34.5.11 | 2‑L | 3283-9 | LA-Bestät. dRVVT | 2.16.840.1.113883.6.1 | 2‑L | LABDQ | LA-Bestät. dRVVT ql. | 1.2.40.0.34.5.11 | 2‑L | LABDR | LA-Bestät. dRVVT-Rto | 1.2.40.0.34.5.11 | 2‑L | 3281-3 | LA Interpretation | 2.16.840.1.113883.6.1 | 2‑L | 8062-2 | Cardiolipin-AK | 2.16.840.1.113883.6.1 | 2‑L | 8063-0 | Cardiolipin-AK IgA | 2.16.840.1.113883.6.1 | 2‑L | 8065-5 | Cardiolipin-AK IgG | 2.16.840.1.113883.6.1 | 2‑L | 8067-1 | Cardiolipin-AK IgM | 2.16.840.1.113883.6.1 | 2‑L | 40456-6 | B2-Glykoprot.-I AK | 2.16.840.1.113883.6.1 | 2‑L | 21108-6 | B2-GPI-AK IgA | 2.16.840.1.113883.6.1 | 2‑L | 40595-1 | Prothrombin-AK IgG | 2.16.840.1.113883.6.1 | 2‑L | 40596-9 | Prothrombin-AK IgM | 2.16.840.1.113883.6.1 | 2‑L | 14245-5 | PS-AK IgG | 2.16.840.1.113883.6.1 | 2‑L | 14246-3 | PS-AK IgM | 2.16.840.1.113883.6.1 | 2‑L | PSREG | Phosphatids.-AK IgG | 1.2.40.0.34.5.11 | 2‑L | PSREM | Phosphatids.-AK IgM | 1.2.40.0.34.5.11 | 2‑L | 7801-4 | Phospholipid-AK IgG | 2.16.840.1.113883.6.1 | 2‑L | 7802-2 | Phospholipid-AK IgM | 2.16.840.1.113883.6.1 | 2‑L | 27818-4 | Protein C Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 27820-0 | Protein C Antigen | 2.16.840.1.113883.6.1 | 2‑L | PCPWY | Protein C Pathw. | 1.2.40.0.34.5.11 | 2‑L | PCP5D | Prot.C Pwy(V-d.Pl.) | 1.2.40.0.34.5.11 | 2‑L | 31102-7 | Protein S Aktivität | 2.16.840.1.113883.6.1 | 2‑L | 27821-8 | Protein S AG, freies | 2.16.840.1.113883.6.1 | 2‑L | 27823-4 | Protein S AG, gesamt | 2.16.840.1.113883.6.1 | 2‑L | APCRZ | APC-Res. (Ger.Z.) | 1.2.40.0.34.5.11 | 2‑L | APCRQ | APC-Resistenz(qual.) | 1.2.40.0.34.5.11 | 2‑L | 13590-5 | APC-Resistenz(Ratio) | 2.16.840.1.113883.6.1 | 2‑L | 48590-4 | aPTT u. Zusatz v.APC | 2.16.840.1.113883.6.1 | 2‑L | 21668-9 | Faktor V Leiden Mut. | 2.16.840.1.113883.6.1 | 2‑L | 24475-6 | Prothr.-Mut.20210G>A | 2.16.840.1.113883.6.1 | 2‑L | 28060-2 | MTHFR-Mut. 1298A>C | 2.16.840.1.113883.6.1 | 2‑L | 28005-7 | MTHFR-Mut. 677C>T | 2.16.840.1.113883.6.1 | 2‑L | PA675 | PAI-1 Mut. 675 4G/5G | 1.2.40.0.34.5.11 | 2‑L | PA844 | PAI-1 Mut. 844A>G | 1.2.40.0.34.5.11 | 0‑S | 500 | Klinische Chemie | 1.2.40.0.34.5.11 | 1‑S | 501 | Entzündungsmarker | 1.2.40.0.34.5.11 | 2‑L | 1988-5 | CRP | 2.16.840.1.113883.6.1 | 2‑L | 48498-0 | Serum - Amyloid A | 2.16.840.1.113883.6.1 | 2‑L | 33864-0 | Elastase | 2.16.840.1.113883.6.1 | 2‑L | 30152-3 | Mannose bind.Prot. | 2.16.840.1.113883.6.1 | 2‑L | 26881-3 | Interleukin-6 | 2.16.840.1.113883.6.1 | 2‑L | 3074-2 | TNF-Alpha | 2.16.840.1.113883.6.1 | 2‑L | 33959-8 | Procalcitonin | 2.16.840.1.113883.6.1 | 2‑L | 4537-7 | Blutsenkung 1h | 2.16.840.1.113883.6.1 | 2‑L | 18184-2 | Blutsenkung 2h | 2.16.840.1.113883.6.1 | 2‑L | V00007 | Blutsenkung Interpr. | 1.2.40.0.34.5.11 | 1‑S | 502 | Niere/Elektrolyte | 1.2.40.0.34.5.11 | 2‑L | 2692-2 | Osmolalitaet | 2.16.840.1.113883.6.1 | 2‑L | 12186-3 | Kolloidosmot. Druck | 2.16.840.1.113883.6.1 | 2‑L | 2823-3 | Kalium | 2.16.840.1.113883.6.1 | 2‑L | 2951-2 | Natrium | 2.16.840.1.113883.6.1 | 2‑L | 2075-0 | Chlorid | 2.16.840.1.113883.6.1 | 2‑L | 2000-8 | Calcium | 2.16.840.1.113883.6.1 | 2‑L | 1995-0 | Calcium ionisiert | 2.16.840.1.113883.6.1 | 2‑L | 14879-1 | Phosphat | 2.16.840.1.113883.6.1 | 2‑L | 13454-4 | Calcium-Phos.-Prod. | 2.16.840.1.113883.6.1 | 2‑L | 2601-3 | Magnesium | 2.16.840.1.113883.6.1 | 2‑L | 2160-0 | Kreatinin | 2.16.840.1.113883.6.1 | 2‑L | 29463-7 | Körpergewicht | 2.16.840.1.113883.6.1 | 2‑L | 8302-2 | Körpergröße | 2.16.840.1.113883.6.1 | 2‑L | 3140-1 | Körperoberfläche | 2.16.840.1.113883.6.1 | 2‑L | SAMP | SAMP | 1.2.40.0.34.5.11 | 2‑L | VL24U | VL24U | 1.2.40.0.34.5.11 | 2‑L | 2164-2 | Kreatinin Clearance | 2.16.840.1.113883.6.1 | 2‑L | 12195-4 | Kreat.Clear./1.7m2KO | 2.16.840.1.113883.6.1 | 2‑L | 33914-3 | GFR/1.7m2KO (MDRD) | 2.16.840.1.113883.6.1 | 2‑L | GFRCG | GFRCG | 1.2.40.0.34.5.11 | 2‑L | 33863-2 | Cystatin C | 2.16.840.1.113883.6.1 | 2‑L | 50210-4 | GFR/1.7m2KO (Cy-C) | 2.16.840.1.113883.6.1 | 2‑L | 3094-0 | BUN | 2.16.840.1.113883.6.1 | 2‑L | 3098-1 | Harnstoff-Clearance | 2.16.840.1.113883.6.1 | 2‑L | BUNVO | BUNVO | 1.2.40.0.34.5.11 | 2‑L | BUNNA | BUNNA | 1.2.40.0.34.5.11 | 2‑L | BUNRR | BUNRR | 1.2.40.0.34.5.11 | 2‑L | 3084-1 | Harnsäure | 2.16.840.1.113883.6.1 | 1‑S | 503 | Kardiale Marker | 1.2.40.0.34.5.11 | 2‑L | 2157-6 | CK | 2.16.840.1.113883.6.1 | 2‑L | 32673-6 | CK-MB | 2.16.840.1.113883.6.1 | 2‑L | 13969-1 | CK - MB (Massenk.) | 2.16.840.1.113883.6.1 | 2‑L | 20569-0 | CK-MB rel. | 2.16.840.1.113883.6.1 | 2‑L | 49136-5 | CK-MBm/CK Rel.Ind. | 2.16.840.1.113883.6.1 | 2‑L | 12187-1 | CK-MB rel. Elpho | 2.16.840.1.113883.6.1 | 2‑L | 9642-0 | CK-BB rel. | 2.16.840.1.113883.6.1 | 2‑L | 49129-0 | CK-MiMi rel. | 2.16.840.1.113883.6.1 | 2‑L | 9643-8 | CK-MM rel. | 2.16.840.1.113883.6.1 | 2‑L | 26019-0 | Makro-CK Typ I rel. | 2.16.840.1.113883.6.1 | 2‑L | 2639-3 | Myoglobin | 2.16.840.1.113883.6.1 | 2‑L | 6598-7 | Troponin T | 2.16.840.1.113883.6.1 | 2‑L | 10839-9 | Troponin I | 2.16.840.1.113883.6.1 | 2‑L | 30934-4 | BNP | 2.16.840.1.113883.6.1 | 2‑L | 33762-6 | NT-pro-BNP | 2.16.840.1.113883.6.1 | 1‑S | 504 | Leber/Pankreas | 1.2.40.0.34.5.11 | 2‑L | 16362-6 | Ammoniak | 2.16.840.1.113883.6.1 | 2‑L | 1920-8 | ASAT (GOT) | 2.16.840.1.113883.6.1 | 2‑L | 1742-6 | ALAT (GPT) | 2.16.840.1.113883.6.1 | 2‑L | 2324-2 | Gamma-GT | 2.16.840.1.113883.6.1 | 2‑L | 6768-6 | Alk.Phosphatase (AP) | 2.16.840.1.113883.6.1 | 2‑L | 26010-9 | AP-atyp.Frakt. rel. | 2.16.840.1.113883.6.1 | 2‑L | 15348-6 | AP-Fast Liver rel. | 2.16.840.1.113883.6.1 | 2‑L | 15014-4 | AP-intestinal rel. | 2.16.840.1.113883.6.1 | 2‑L | 1777-2 | AP-Knochen | 2.16.840.1.113883.6.1 | 2‑L | 15013-6 | AP-Knochen rel. | 2.16.840.1.113883.6.1 | 2‑L | 15015-1 | AP-Leber rel. | 2.16.840.1.113883.6.1 | 2‑L | 15016-9 | AP-Plazenta rel. | 2.16.840.1.113883.6.1 | 2‑L | 17838-4 | AP-Knochen(Massenk.) | 2.16.840.1.113883.6.1 | 2‑L | 2098-2 | Cholinesterase | 2.16.840.1.113883.6.1 | 2‑L | 1975-2 | Bilirubin | 2.16.840.1.113883.6.1 | 2‑L | 1968-7 | Bilirubin, direktes | 2.16.840.1.113883.6.1 | 2‑L | 1971-1 | Bilirubin, indir. | 2.16.840.1.113883.6.1 | 2‑L | 15152-2 | Bilirubin, konjug. | 2.16.840.1.113883.6.1 | 2‑L | V00001 | Bilirubin, Neonatal- | 1.2.40.0.34.5.11 | 2‑L | 5631-7 | Kupfer | 2.16.840.1.113883.6.1 | 2‑L | 2064-4 | Coeruloplasmin | 2.16.840.1.113883.6.1 | 2‑L | 2572-6 | Lipase | 2.16.840.1.113883.6.1 | 2‑L | 1798-8 | Alpha-Amylase | 2.16.840.1.113883.6.1 | 2‑L | 1805-1 | Pankreas-Amylase | 2.16.840.1.113883.6.1 | 1‑S | 505 | Hämolysemarker | 1.2.40.0.34.5.11 | 2‑L | 2532-0 | LDH | 2.16.840.1.113883.6.1 | 2‑L | 2537-9 | Alpha-HBDH (LDH-1) | 2.16.840.1.113883.6.1 | 2‑L | 2536-1 | LDH Isoenzym 1 rel. | 2.16.840.1.113883.6.1 | 2‑L | 49930-1 | LDH Plp./Ser-Rto | 2.16.840.1.113883.6.1 | 2‑L | 2539-5 | LDH-Isoenzym 2 rel. | 2.16.840.1.113883.6.1 | 2‑L | 2542-9 | LDH-Isoenzym 3 rel. | 2.16.840.1.113883.6.1 | 2‑L | 2545-2 | LDH-Isoenzym 4 rel. | 2.16.840.1.113883.6.1 | 2‑L | 2548-6 | LDH-Isoenzym 5 rel. | 2.16.840.1.113883.6.1 | 2‑L | 4635-9 | Freies Hämoglobin /S | 2.16.840.1.113883.6.1 | 2‑L | 721-1 | Freies Hämoglobin /P | 2.16.840.1.113883.6.1 | 2‑L | 4542-7 | Haptoglobin | 2.16.840.1.113883.6.1 | 2‑L | 2403-4 | Hämopexin | 2.16.840.1.113883.6.1 | 1‑S | 506 | Eisenstoffwechsel | 1.2.40.0.34.5.11 | 2‑L | 2498-4 | Eisen | 2.16.840.1.113883.6.1 | 2‑L | 50198-1 | Eisen Abnahme 1 | 2.16.840.1.113883.6.1 | 2‑L | 50199-9 | Eisen Abnahme 2 | 2.16.840.1.113883.6.1 | 2‑L | 50200-5 | Eisen Abnahme 3 | 2.16.840.1.113883.6.1 | 2‑L | 50201-3 | Eisen Abnahme 4 | 2.16.840.1.113883.6.1 | 2‑L | 50202-1 | Eisen Abnahme 5 | 2.16.840.1.113883.6.1 | 2‑L | 50203-9 | Eisen Abnahme 6 | 2.16.840.1.113883.6.1 | 2‑L | 50204-7 | Eisen Abnahme 7 | 2.16.840.1.113883.6.1 | 2‑L | 50205-4 | Eisen Abnahme 8 | 2.16.840.1.113883.6.1 | 2‑L | 3034-6 | Transferrin | 2.16.840.1.113883.6.1 | 2‑L | 2505-6 | Transferrinsättigung | 2.16.840.1.113883.6.1 | 2‑L | 30248-9 | Lösl.Trf-Rez.(sTfR) | 2.16.840.1.113883.6.1 | 2‑L | 2276-4 | Ferritin | 2.16.840.1.113883.6.1 | 2‑L | 48497-2 | Pro-Hepcidin | 2.16.840.1.113883.6.1 | 1‑S | 507 | Glukosestoffwechsel | 1.2.40.0.34.5.11 | 2‑L | 2345-7 | Glucose | 2.16.840.1.113883.6.1 | 2‑L | 16915-1 | Glukose postprandial | 2.16.840.1.113883.6.1 | 2‑L | 15069-8 | Fructosamin | 2.16.840.1.113883.6.1 | 2‑L | 4548-4 | Hämoglobin A1c | 2.16.840.1.113883.6.1 | 2‑L | 2524-7 | Laktat | 2.16.840.1.113883.6.1 | 2‑L | 39998-0 | Gluc.30 min vor Bel. | 2.16.840.1.113883.6.1 | 2‑L | 48983-1 | Gluc.20 min vor Bel. | 2.16.840.1.113883.6.1 | 2‑L | 12651-6 | Gluc.10 min vor Bel. | 2.16.840.1.113883.6.1 | 2‑L | 1547-9 | Gluc. 0 min (nücht.) | 2.16.840.1.113883.6.1 | 2‑L | 48984-9 | Glucose 10min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 48985-6 | Glucose 20min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 20439-6 | Glucose 30min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 26539-7 | Glucose 45min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 20438-8 | Glucose 60min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 20440-4 | Glucose 90min (oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 20436-2 | Glucose 120min(oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 20437-0 | Glucose 180min(oGTT) | 2.16.840.1.113883.6.1 | 2‑L | 12638-3 | Gluc.vor Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 12648-2 | Gluc.15min n.Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 26777-3 | Gluc.30min n.Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 26778-1 | Gluc.60min n.Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 26779-9 | Gluc.90min n.Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 26780-7 | Gluc.120min n.Lactoseb. | 2.16.840.1.113883.6.1 | 2‑L | 50206-2 | Glucose Abnahme 1 | 2.16.840.1.113883.6.1 | 2‑L | 50212-0 | Glucose Abnahme 2 | 2.16.840.1.113883.6.1 | 2‑L | 50213-8 | Glucose Abnahme 3 | 2.16.840.1.113883.6.1 | 2‑L | 50214-6 | Glucose Abnahme 4 | 2.16.840.1.113883.6.1 | 2‑L | 50215-3 | Glucose Abnahme 5 | 2.16.840.1.113883.6.1 | 2‑L | 50216-1 | Glucose Abnahme 6 | 2.16.840.1.113883.6.1 | 2‑L | 50207-0 | Glucose Abnahme 7 | 2.16.840.1.113883.6.1 | 2‑L | 50217-9 | Glucose Abnahme 8 | 2.16.840.1.113883.6.1 | 2‑L | 50218-7 | Glucose Abnahme 9 | 2.16.840.1.113883.6.1 | 2‑L | 50208-8 | Glucose Abnahme 10 | 2.16.840.1.113883.6.1 | 2‑L | 48993-0 | Glucose-Prof. 3 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48994-8 | Glucose-Prof. 6 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48986-4 | Glucose-Prof. 8 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 16165-3 | Glucose-Prof. 10 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48988-0 | Glucose-Prof. 12 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 16167-9 | Glucose-Prof. 14 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 16169-5 | Glucose-Prof. 16 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48989-8 | Glucose-Prof. 18 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48990-6 | Glucose-Prof. 20 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48991-4 | Glucose-Prof. 22 Uhr | 2.16.840.1.113883.6.1 | 2‑L | 48992-2 | Glucose-Prof. 24 Uhr | 2.16.840.1.113883.6.1 | 1‑S | 508 | Fettstoffwechsel | 1.2.40.0.34.5.11 | 2‑L | 2093-3 | Cholesterin | 2.16.840.1.113883.6.1 | 2‑L | 2085-9 | HDL-Cholesterin | 2.16.840.1.113883.6.1 | 2‑L | 2089-1 | LDL-Cholesterin | 2.16.840.1.113883.6.1 | 2‑L | 13457-7 | LDL-Chol. berechnet | 2.16.840.1.113883.6.1 | 2‑L | 9830-1 | Chol./HDL-Ch.-Ratio | 2.16.840.1.113883.6.1 | 2‑L | 11054-4 | LDL/HDL-Chol.-Ratio | 2.16.840.1.113883.6.1 | 2‑L | 2571-8 | Triglyceride | 2.16.840.1.113883.6.1 | 2‑L | 49131-6 | Chylomikronen rel. | 2.16.840.1.113883.6.1 | 2‑L | 15121-7 | Alpha-Lipopr. rel. | 2.16.840.1.113883.6.1 | 2‑L | 15123-3 | Präbeta-Lipopr. rel. | 2.16.840.1.113883.6.1 | 2‑L | 15122-5 | Beta-Lipopr. rel. | 2.16.840.1.113883.6.1 | 2‑L | 49133-2 | VLDL-Chol. Elpho | 2.16.840.1.113883.6.1 | 2‑L | 49130-8 | HDL-Chol. Elpho | 2.16.840.1.113883.6.1 | 2‑L | 49132-4 | LDL-Chol. Elpho | 2.16.840.1.113883.6.1 | 2‑L | 5911-3 | Lipoproteinbefund | 2.16.840.1.113883.6.1 | 2‑L | 1869-7 | Apolipoprotein A1 | 2.16.840.1.113883.6.1 | 2‑L | 1870-5 | Apolipoprotein A2 | 2.16.840.1.113883.6.1 | 2‑L | 1878-8 | Apolipoprotein A3 | 2.16.840.1.113883.6.1 | 2‑L | 1884-6 | Apolipoprotein B | 2.16.840.1.113883.6.1 | 2‑L | 10835-7 | Lipoprotein (a) | 2.16.840.1.113883.6.1 | 1‑S | 509 | Proteindiagnostik | 1.2.40.0.34.5.11 | 2‑L | 2885-2 | Totalprotein | 2.16.840.1.113883.6.1 | 2‑L | 49929-3 | TP Plp./Ser-Rto | 2.16.840.1.113883.6.1 | 2‑L | 1751-7 | Albumin | 2.16.840.1.113883.6.1 | 2‑L | 13980-8 | Albumin rel. Elpho | 2.16.840.1.113883.6.1 | 2‑L | 13978-2 | Alpha-1-Globulin rl. | 2.16.840.1.113883.6.1 | 2‑L | 13981-6 | Alpha-2-Globulin rl. | 2.16.840.1.113883.6.1 | Dieses Value Set beinhaltet 1788 Codes. Um die Publikationsgröße überschaubar zu halten, wird nur eine Auswahl (500 Codes) des ganzen Sets von Codes gezeigt. |
|
|
Legende: Typ L=leaf, S=specializable, A=abstract, D=deprecated. NullFlavors werden im @nullFlavor Attribut statt in @code angegeben. |